
HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …

Dutch pharmacists have vowed to circumvent rules enforcing Novartis’ market exclusivity for radioactive cancer drug Lutathera. Pharmacists at Erasmus, …

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

Among the swirling storm emanating from the testimony of Donald Trump’s ex-lawyer Michael Cohen to the House Oversight Committee, one …

Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …

The FDA has taken the decision to authorise the use of Novartis’ Egaten (triclabendazole) in patients older than six years …

Novartis has arranged to sell the remainder of its rights to its skin and lung cancer drug Proleukin (aldesleukin, recombinant …

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …

It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …